MedPath

IRCCS ISTITUTO NAZIONALE TUMORI - FONDAZIONE PASCALE

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma

Phase 1
Conditions
Recurrent Adult Hodgkin Lymphoma
Interventions
Other: Bio-specimen Retention
First Posted Date
2011-08-09
Last Posted Date
2015-08-11
Lead Sponsor
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Target Recruit Count
36
Registration Number
NCT01412307
Locations
🇮🇹

Hematology Oncology and Stem Cell Transplantation Unit , IRCCS Fondazione "G.Pascale", Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath